Furthermore, PACSIN2 polymorphism was shown to be linked with thiopurine-induced hematological toxicity in children receiving maintenance therapy aimed at treating ALL (Smid et al., 2016). Here, PACSIN2 is linked to acute lymphoblastic leukemia.